ZyVersa Therapeutics Highlights Review Article Substantiating That Inflammasome Activation Is Pathogenic in Multiple Neurological Diseases
February 14, 2024 07:53 ET | ZyVersa Therapeutics
Inflammation resulting from activation of more than one type inflammasome and ASC specks contribute to development and progression of neurological disease
Straits Research Pvt Ltd
Global Active Implantable Medical Devices Market Size is Estimated to Reach USD 42.35 billion by 2031, Growing at a CAGR of 7.2%: Straits Research
January 17, 2024 10:30 ET | Straits Research
New York, United States, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Active medical implantable devices are made to be inserted into the body. These are designed to be injected into the body and remain there...
Emergen logo.png
Clinical Biomarkers Market Size to Reach USD 63.04 Billion in 2032 | Emergen Research
December 12, 2023 07:31 ET | Emergen Research
Vancouver, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The global clinical biomarkers market is expected to reach a market size of USD 63.04 billion at a steady CAGR of 10.2% in 2032, according to latest...
ZyVersa Therapeutics Announces Publication of an Article in the Journal of Neuroinflammation Addressing the Role of ASC Specks in Propagation of Alpha-Synuclein Pathology in Parkinson’s Disease
April 25, 2023 09:07 ET | ZyVersa Therapeutics
Parkinson’s disease (“PD”), the second leading cause of neurodegeneration in the world, is characterized by progressive degeneration of nigrostriatal dopaminergic neurons and intracellular...
Global Neuromodulation Devices Market to Undergo Significant Growth Due to Rising Adoption for Neuromodulation Devices in COVID-19 Pandemic – Exclusive Report [150 Pages] By Research Dive
August 25, 2021 09:02 ET | Research Dive
New York, USA, Aug. 25, 2021 (GLOBE NEWSWIRE) -- A latest report on the global neuromodulation devices market published by Research Dive sheds light on the impact of COVID-19 pandemic on the current...
Vyant Bio and Cyclica Announce a Strategic Collaboration to Identify Compounds to Treat CDKL5 Deficiency Disorder
August 19, 2021 09:27 ET | Vyant Bio, Inc.
CDKL5 Deficiency Disorder (“CDD”) is a severe neurodevelopmental epileptic encephalopathy disorder with no effective treatments or cureCollaboration creates opportunities to identify, validate, and...
Elsevier and the International Society for Neurovascular Disease Partner on Co-branded Neurovascular Disease Book Series
September 29, 2016 04:00 ET | Elsevier, Inc.
CAMBRIDGE, MA--(Marketwired - September 29, 2016) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it has partnered...